Medadvisor Ltd
Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom. The company offers THRiV, an omni-channel platform which provides pharmacy-driven patient and pharmacist engagement solutions to improve medication management. The company was formerly known as MedAdvisor Limited and changed its anm… Read more
Medadvisor Ltd (MDR) - Net Assets
Latest net assets as of June 2025: AU$-1.62 Million AUD
Based on the latest financial reports, Medadvisor Ltd (MDR) has net assets worth AU$-1.62 Million AUD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$39.84 Million) and total liabilities (AU$41.46 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$-1.62 Million |
| % of Total Assets | -4.06% |
| Annual Growth Rate | N/A |
| 5-Year Change | -103.31% |
| 10-Year Change | -165.64% |
| Growth Volatility | 134.5 |
Medadvisor Ltd - Net Assets Trend (2011–2025)
This chart illustrates how Medadvisor Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Medadvisor Ltd (2011–2025)
The table below shows the annual net assets of Medadvisor Ltd from 2011 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$-1.62 Million | -103.14% |
| 2024-06-30 | AU$51.58 Million | +6.44% |
| 2023-06-30 | AU$48.46 Million | +40.28% |
| 2022-06-30 | AU$34.55 Million | -29.28% |
| 2021-06-30 | AU$48.85 Million | +186.98% |
| 2020-06-30 | AU$17.02 Million | +96.89% |
| 2019-06-30 | AU$8.64 Million | -43.01% |
| 2018-06-30 | AU$15.17 Million | +62.16% |
| 2017-06-30 | AU$9.35 Million | +279.57% |
| 2016-06-30 | AU$2.46 Million | +2405.75% |
| 2015-06-30 | AU$-106.88K | -134.37% |
| 2014-06-30 | AU$310.98K | -97.20% |
| 2013-06-30 | AU$11.11 Million | +299.55% |
| 2012-06-30 | AU$2.78 Million | -11.43% |
| 2011-06-30 | AU$3.14 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Medadvisor Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 13222965000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$123.67 Million | % |
| Other Comprehensive Income | AU$7.01 Million | % |
| Total Equity | AU$-1.62 Million | 100.00% |
Medadvisor Ltd Competitors by Market Cap
The table below lists competitors of Medadvisor Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Visionary Metals Corp.
F:339
|
$5.36 Million |
|
TOKAIDO REIT INC.
F:AI70
|
$5.36 Million |
|
Asahi Songwon Colors Limited
NSE:ASAHISONG
|
$5.36 Million |
|
Agroz Inc. Ordinary Shares
NASDAQ:AGRZ
|
$5.36 Million |
|
Canoo Inc
NASDAQ:GOEV
|
$5.36 Million |
|
Reallusion Inc.
TWO:6882
|
$5.36 Million |
|
Lux Metals Corp.
F:GP80
|
$5.36 Million |
|
Next Science Limited
PINK:NXSCF
|
$5.36 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medadvisor Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 51,583,433 to -1,617,738, a change of -53,201,171 (-103.1%).
- Net loss of 60,208,977 reduced equity.
- Other comprehensive income decreased equity by 115,114.
- Other factors increased equity by 7,122,920.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-60.21 Million | -3721.8% |
| Other Comprehensive Income | AU$-115.11K | -7.12% |
| Other Changes | AU$7.12 Million | +440.3% |
| Total Change | AU$- | -103.14% |
Book Value vs Market Value Analysis
This analysis compares Medadvisor Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-06-30 | AU$2.94 | AU$0.02 | x |
| 2012-06-30 | AU$0.75 | AU$0.02 | x |
| 2013-06-30 | AU$1.40 | AU$0.02 | x |
| 2014-06-30 | AU$0.03 | AU$0.02 | x |
| 2015-06-30 | AU$-0.01 | AU$0.02 | x |
| 2016-06-30 | AU$0.03 | AU$0.02 | x |
| 2017-06-30 | AU$0.08 | AU$0.02 | x |
| 2018-06-30 | AU$0.09 | AU$0.02 | x |
| 2019-06-30 | AU$0.04 | AU$0.02 | x |
| 2020-06-30 | AU$0.07 | AU$0.02 | x |
| 2021-06-30 | AU$0.15 | AU$0.02 | x |
| 2022-06-30 | AU$0.09 | AU$0.02 | x |
| 2023-06-30 | AU$0.09 | AU$0.02 | x |
| 2024-06-30 | AU$0.09 | AU$0.02 | x |
| 2025-06-30 | AU$0.00 | AU$0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medadvisor Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -95.58%
- • Asset Turnover: 1.58x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-273.19%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | -2.24% | -292.62% | 0.01x | 1.09x | AU$-384.18K |
| 2012 | -35.73% | -827.84% | 0.04x | 1.18x | AU$-1.27 Million |
| 2013 | -33.73% | -437.15% | 0.07x | 1.07x | AU$-4.86 Million |
| 2014 | -3583.50% | -1046.14% | 1.51x | 2.27x | AU$-11.18 Million |
| 2015 | 0.00% | -40.53% | 8.32x | 0.00x | AU$-656.28K |
| 2016 | -124.62% | -215.39% | 0.39x | 1.48x | AU$-3.32 Million |
| 2017 | -36.67% | -80.84% | 0.38x | 1.19x | AU$-4.37 Million |
| 2018 | -29.36% | -67.44% | 0.38x | 1.15x | AU$-5.97 Million |
| 2019 | -93.71% | -98.29% | 0.70x | 1.36x | AU$-8.97 Million |
| 2020 | -57.53% | -99.82% | 0.45x | 1.28x | AU$-11.25 Million |
| 2021 | -28.79% | -35.98% | 0.48x | 1.67x | AU$-18.79 Million |
| 2022 | -50.21% | -25.60% | 0.86x | 2.27x | AU$-20.80 Million |
| 2023 | -23.33% | -11.54% | 1.02x | 1.98x | AU$-16.15 Million |
| 2024 | 1.54% | 0.65% | 1.24x | 1.92x | AU$-4.37 Million |
| 2025 | 0.00% | -95.58% | 1.58x | 0.00x | AU$-60.05 Million |
Industry Comparison
This section compares Medadvisor Ltd's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $19,142,795
- Average return on equity (ROE) among peers: -52.12%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medadvisor Ltd (MDR) | AU$-1.62 Million | -2.24% | N/A | $5.36 Million |
| Adheris Health Limited (AHE) | $51.58 Million | 1.54% | 0.92x | $119.94 |
| Alcidion Group Ltd (ALC) | $6.57 Million | -38.71% | 0.23x | $60.88 Million |
| ARTRYA Ltd (AYA) | $40.64 Million | -42.21% | 0.08x | $148.36 Million |
| Blinklab Ltd (BB1) | $6.48 Million | -27.04% | 0.06x | $39.10 Million |
| Beamtree Holdings Ltd (BMT) | $29.22 Million | 1.31% | 0.10x | $18.03 Million |
| Cogstate Ltd (CGS) | $29.02 Million | 24.18% | 1.36x | $124.86 Million |
| Careteq Ltd (CTQ) | $3.55 Million | -121.85% | 1.13x | $621.63K |
| Doctor Care Anywhere Group Plc (DOC) | $12.29 Million | -179.31% | 0.79x | $21.76 Million |
| Echoiq Ltd (EIQ) | $6.77 Million | -79.92% | 0.22x | $168.60 Million |
| Emyria Ltd (EMD) | $5.31 Million | -59.24% | 0.25x | $11.75 Million |